News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

July

13

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

11

electroCore Provides Select Second Quarter 2023 Financial Guidance

Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65%...

6

gammaCore™ Selected for Study Funded by NFL and NFL Players Association on Alleviating Concussion Symptoms

Research grants jointly awarded to independent medical researchers studying alternative pain management treatments at...

27

electroCore’s TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project

ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and...

12

TriSalus Presents Additional Data for SD-101 Delivered by Proprietary PEDD™ Method with TriNav™ Device for Uveal Melanoma Liver Metastases at ASCO Annual Meeting

New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the...

26

electroCore, Inc. Announces Departure of JP Errico from the Board of Directors

ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and...

15

Exagen Inc. Reports First Quarter 2023 Results

Record Physician Demand for AVISE® CTD SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN)(“Exagen”), a...

4

ATEC Reports First Quarter 2023 Financial Results

CARLSBAD, Calif.–(BUSINESS WIRE)–May 4, 2023– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative...

3

electroCore Announces First Quarter 2023 Financial Results

Record first quarter 2023 net sales of $2.8 million, approximately 46% over first quarter 2022 ROCKAWAY, N.J., May 03,...

26

National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders

ROCKAWAY, N.J., April 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and...

24

Study Presented at 75th Annual Meeting of the American Academy of Neurology Demonstrates that gammaCore (nVNS) Can Accelerate Foreign Language Learning

Clinical trial (n=36) shows the ability of gammaCore (nVNS) to significantly improve the recall...

20

Neurolens Measures Its One Millionth Patient

DALLAS, April 20, 2023 – Neurolens, a company commercializing innovative solutions to optimize vision, announced...